Delta Life Insurance financial analysis: flat life fund, negative operating cash flow, EPS doubled to BDT 8.64 (Oct 2026)

Investment considerations: a big, high-yielding fund that stopped growing, now restarting under a reconstituted board

Delta Life Insurance Company Ltd. (Delta Life) is the country's first private-sector life insurer, according to The Business Standard [17], and was set up in 1986 [11]. It sells individual endowment-type savings policies through agents in two retail lines, ordinary life (OL) and Gono-Grameen Bima (GN-GRB), a micro-insurance line for rural households, plus group life and group health and, since 2025, a small bancassurance line [1 p.113] [1 p.34]. In 2025 it wrote BDT 10,231m of gross premium, up 7.9%, and its life fund was BDT 40,729m [1 p.17] [1 p.18]. It owns one subsidiary, the stockbroker DLIC Securities Ltd. [1 p.34].

Reading a Bangladeshi life insurer starts with the life fund, which belongs mainly to policyholders. Premiums and investment income flow into it; claims, cash bonuses, commissions, expenses, tax and the shareholders' dividend flow out [1 p.113] [1 p.115]. An actuary values the policy liabilities each year and certifies how much surplus is available to shareholders. That is Delta's earnings: the 2025 EPS of BDT 8.64 is BDT 1,069.7m of shareholders' surplus divided by 123.75m shares [1 p.151]. Delta does not disclose the total surplus or the policyholder bonus allocation in the pages we read, so the shareholders' share of the total cannot be computed (see gaps).

Delta's story over the past decade is a governance one as much as a business one. The insurance regulator, IDRA, suspended the board in February 2021 and appointed an administrator, as reported by both The Business Standard and The Financial Express [12] [13]. The administrator was withdrawn and a reconstituted board took over on 20-Sep-2022 [15] [16]. The 2019 and 2020 financial statements were not signed until 31-Oct-2023 [7 p.77] [6 p.79]. The numbers below cover the period before, during and after that disruption.

Business: agency savings plus a large rural micro-insurance book; bancassurance is new

Delta's premium comes from two retail books of roughly similar size in renewals. In 2025 ordinary life wrote BDT 1,194m of first-year premium and BDT 4,273m of renewals; Gono-Grameen wrote BDT 832m and BDT 3,042m [1 p.113]. Gono-Grameen is 39% of new business and 42% of renewals [24]; the company describes it as an affordable insurance net primarily serving Bangladesh's rural poor [1 p.34]. Group life (BDT 458m) and group health (BDT 332m) made up 7.7% of gross premium, between NATLIFEINS (1.1%) and PRAGATILIF (20.6%) [1 p.113] [24].

Bancassurance is new. First-year bancassurance premium was BDT 0.1m in 2024 and BDT 99.0m in 2025 [1 p.113], and BDT 135.1m in the first nine months of 2026 against BDT 52.5m a year earlier [2 p.1]. It is still under 10% of first-year premium, but it is the fastest-growing channel in the accounts.

The products are long. Of the 2025 first-year premium, BDT 1,369m (64%) came from policies with premium terms of twelve years or more and BDT 610m from ten-year terms; single-premium business was BDT 113m [1 p.113]. Long terms mean renewals dominate the top line (72% of gross premium in 2025) and today's maturity claims reflect sales made a decade or more ago [24].

Distribution is through commissioned agents. First-year commission was BDT 668m in 2025; the KFI page reports it as 22.92% of first-year premium, while our calculation from the same page gives 31.4%, a basis difference the filing does not explain [1 p.17] [24]. On either basis it is well below NATLIFEINS, whose reported ratio was 39.60% [8 p.251]. Second-year commission was 9.51% of second-year renewal premium and later-year commission 4.49% [1 p.17].

Regulation sets the economics. The accounts follow the Insurance Act 2010 and the Insurance Rules 1958 alongside IFRS [1 p.35], and there is no separate shareholders' profit and loss: everything runs through the life revenue account and the life fund [1 p.113]. Delta says it cannot present NAV per share or operating cash flow per share until IDRA gazettes a regulation that separates shareholders' and policyholders' funds under section 27(3) of the Insurance Act 2010 [1 p.151] [1 p.152]. For a shareholder, three regulated steps sit between a premium taka and a dividend taka: the IDRA expense limit, the actuary's valuation, and the surplus available to shareholders.

Premium and persistency: 6.3% a year for a decade; conservation is the weakest of three peers

Gross premium grew from BDT 5,887m in 2016 to BDT 10,231m in 2025, a compound 6.3% a year [6 p.19] [1 p.17] [24]. That is slower than NATLIFEINS, whose premium grew 11-18% a year in 2021-2025 [8 p.251]. The weakest years line up with the disruption: first-year premium fell 24.4% in 2020, the year before the administrator, and fell again by 6.4% in 2024 [6 p.19] [1 p.17]. It rebounded 38.5% in 2021 and 16.7% in 2025. In 9M 2026 first-year premium rose 16.3% and renewals 10.8% [2 p.1] [24].

First-year vs renewal: renewal premium is the steadier engine. It grew every year in the decade, from BDT 4,208m to BDT 7,316m, while first-year premium went from BDT 1,227m to BDT 2,125m with two down years [6 p.19] [1 p.17]. First-year premium has been 17-22% of gross premium throughout [24], so Delta is not shrinking its new-business engine, but it has not accelerated it either.

Persistency is the core question for a savings book. A simple test is the renewal ratio: this year's renewal premium over last year's first-year plus renewal premium. It was 84.0% in 2025 and stayed in a 78.5%-86.5% band from 2017 to 2025 [24]. The IDRA conservation ratio, which the company reports, was 77.14% in 2025 and 74.86-78.59% over 2021-2025 [1 p.17]. Both say roughly one premium taka in five does not come back the next year.

Lapses: Delta's reported lapse ladder looks much better than its peers', but it is not on the same basis. Delta reports a second-policy-year lapse ratio of 28.86% by number and 27.78% by premium for 2025, and a sixth-year ratio of only 6.43% [1 p.17] [1 p.18]. NATLIFEINS reports 39.93% and 57.80% [8 p.251] [8 p.252]; PRAGATILIF 47.88% and 76.99% [9 p.126]. Delta's ladder falls with policy year while the peers' rises, and Delta footnotes its formula as (L t,t-1 / N t-1) x 100 [1 p.18], which reads as lapses in the year over policies in force at the start of the year, not cumulative lapses since issue. We therefore do not compare Delta's lapse ratios with peers; the conservation ratio (77.1% vs 81.8% and 78.7%) is the like-for-like measure, and on it Delta is the weakest of the three [1 p.17] [8 p.251] [9 p.126].

The cohort table points the same way. Of the first-year premium written in 2021 (BDT 1,640.6m), BDT 695.0m renewed in 2022, BDT 797.1m in 2023, BDT 583.8m in 2024 and BDT 797.2m in 2025 [1 p.18]. The number of new policies issued was 0.15m in both 2024 and 2025, down from 0.18m in 2022 [1 p.18]; growth in first-year premium in 2025 therefore came from larger policies, not more of them.

Expenses: always under the IDRA limit since 2021, but with only 2.9% to spare

IDRA sets an allowable management expense for each life insurer, based on its premium mix, and the KFI page reports actual against allowable. Delta stayed under the limit in all five years 2021-2025, but the margin narrowed from 9.5% (BDT 224m) in 2021 to 1.8% (BDT 48m) in 2024, and was 2.9% (BDT 85m) in 2025 [1 p.17] [24]. NATLIFEINS was 11.96% under its limit and PRAGATILIF 2.25% under in 2025 [8 p.251] [9 p.126].

The overall management expense ratio has been stable: 28.8% of gross premium in 2016, 28.1% in 2025, and between 26.9% and 28.8% in every year between [6 p.19] [1 p.17] [24]. Within it, commission rose to BDT 1,646m in 2025 from BDT 1,464m, 16.1% of gross premium, while salaries were flat at BDT 624m [1 p.114]. The cost base is therefore mostly variable with sales. The renewal expense ratio was 13.84% in 2025 [1 p.17].

Sensitivity, from history only: in 2025 each 1% of gross premium in management expenses was about BDT 102m, and the whole headroom under the limit was BDT 85m, about 0.8% of gross premium [24]. A business that grows faster in group health or bancassurance, where allowances are calculated differently, would change the allowable figure; the filings do not break the allowable figure down.

Claims and the life fund: outgo caught up with income in 2021-2023; 2025 was the first real addition since 2020

Life fund growth: the fund grew by BDT 1.4-2.0bn a year from 2016 to 2020, reaching BDT 41,205m [6 p.19]. It then fell by BDT 1,655m in 2021, BDT 227m in 2022 and BDT 735m in 2023, rose BDT 215m in 2024 and BDT 1,926m in 2025 to BDT 40,729m [1 p.18] [24]. It reached BDT 42,987m at Sep-2026 [2 p.1]. Over the same five years NATLIFEINS's fund grew from BDT 43.9bn to BDT 70.2bn [8 p.252]; in 2020 the two funds were of similar size.

The fund stopped growing because outgo caught up with income. Claims were 128.5% of gross premium in 2021, when claims paid jumped to BDT 9,811m from BDT 6,336m, then 87.5%-95.7% in 2022-2024 (93.0%, 87.5%, 95.7%) and 81.7% in 2025 [1 p.17] [6 p.19]. Claims plus management expenses took 112.1% of premium and investment income in 2021 and 81.3% in 2025, against 73-78% in 2016-2019 [24]. The filings do not say why claims jumped in 2021; maturities of older, larger cohorts and the change of management are possible explanations, but we have no source for either.

The claim mix shifted in 2025. Maturity claims fell to BDT 3,562m from BDT 4,947m, while cash bonuses paid rose to BDT 3,172m from BDT 2,761m and surrenders to BDT 414m from BDT 378m [1 p.114]. Maturities were 42.6% of claims in 2025 against 54.5% in 2024, and cash bonuses 37.9% [24]. In 9M 2026 claims and surrenders rose 14.9% to BDT 5,777m, faster than premium (+12.0%) [2 p.1] [24].

Our walk of the 2025 revenue account reconciles to the reported closing fund to within BDT 0.1m: opening fund BDT 38,803m, plus the released unexpired-risk reserve (BDT 296m), net premium (BDT 10,086m), interest, dividends and rents (BDT 3,590m) and other income (BDT 55m), minus claims (BDT 8,363m), management expenses (BDT 2,870m), a new unexpired-risk reserve (BDT 338m), income tax (BDT 159m) and the dividend appropriation (BDT 371m) [1 p.113] [1 p.114] [1 p.115] [24]. In 2024 the dividend appropriation was BDT 742.5m, twice the BDT 371.25m of a 30% dividend [1 p.115].

Cash flow: eight straight negative years, because claims and expenses exceed premium

Negative operating cash flow years: Delta reported negative operating cash flow in each of the eight years from 2018 to 2025: BDT -1,626m (2018), -190m (2019), -1,725m (2020), -3,757m (2021), -2,476m (2022), -2,564m (2023), -1,721m (2024) and -2,417m (2025) [7 p.77] [6 p.79] [1 p.18]. It was BDT -1,845m in 9M 2026 against BDT -2,720m in 9M 2025 [2 p.1]. NATLIFEINS reported BDT +9,844m and PRAGATILIF BDT +1,143m in 2025 [8 p.252] [9 p.127].

Most of the gap is classification plus the claims burden. Delta puts interest, dividends and rents received in investing activities: BDT 3,252m in 2020 and BDT 2,967m in 9M 2026 [6 p.79] [2 p.1]. Operating cash flow therefore compares premium collected with claims, expenses and tax only, and on that basis Delta's claims and expenses exceed premium. Adding reported investment income back to operating cash flow gives BDT -732m in 2021 and BDT +508m to +1,748m in 2022-2025 [24]: the business is cash-positive only once the fund's income is counted. That is the mechanism behind the flat fund.

Cash and deposits shrank as a result. Cash and cash equivalents were BDT 11,867m at Dec-2019 and BDT 9,631m at Dec-2020 [6 p.79], BDT 2,482m at Dec-2024 and BDT 3,396m at Dec-2025 [1 p.102], and BDT 2,481m at Sep-2026 [2 p.1]. Dividends paid in cash were BDT 622m in 9M 2026 against BDT 304m in 9M 2025 [2 p.1].

Investments: a third in listed shares, a 9.45% reported yield and a BDT 1.2bn related-party holding

Investment mix: Delta runs a much more equity-heavy fund than its peers. At Dec-2025 its consolidated invested assets of BDT 42,843m were 51.9% treasury bonds, 29.4% listed shares and 7.9% bank deposits and cash [1 p.102] [24]. By Sep-2026 listed shares were BDT 15,025m, 32.9% of invested assets and 35.0% of the life fund [2 p.1] [24]. For comparison, NATLIFEINS held BDT 3,829m of shares, bonds, mutual funds and debentures at Dec-2025, about 5.9% of its invested assets on the same lines, against Delta's 33.2% for listed shares plus debentures, bonds and funds [8 p.264] [24].

The equity book is in profit on paper. Form AA shows listed shares at a book value of BDT 9,825m and a market value of BDT 11,240m at Dec-2025, an unrealised gain of BDT 1,415m; mutual funds were BDT 104m under cost [1 p.119] [24]. The fair-value change account in the balance sheet was BDT 1,435m at Dec-2025, BDT 4,083m at Jun-2026 and BDT 3,855m at Sep-2026 [3 p.1] [2 p.1]. Listed shares and mutual funds are carried at fair value, with the unrealised gain or loss in the fair value change account [1 p.127]. A related-party holding stands out: shares of DBH Finance PLC, where Delta has a director, had a market value of BDT 1,237m at Dec-2025 (BDT 1,364m a year earlier), 11.0% of the company's listed-share book at market value (Form AA, BDT 11,240m); Delta also held a BDT 197m FDR with DBH [1 p.151] [4 p.141] [24].

Investment yield: the reported yield on the life fund was 7.67-7.86% in 2021-2023 and 9.39% in 2024 and 9.45% in 2025 [1 p.17]. Our recompute, investment income over the average fund, gives 8.96% and 9.03% [24]. Investment income rose from BDT 2,877m (2023) to BDT 3,590m (2025), as treasury-bond yields rose and the dividend income from shares grew [1 p.17]; in 9M 2026 interest, dividends and rents rose 7.1% [2 p.1] [24]. Sensitivity from history: each 1pp of yield on the 2025 average fund was about BDT 398m of income, roughly a quarter of the year's management expenses [24].

Surplus, EPS and dividends: EPS BDT 8.64, payout 40%, dividend steady at 30-35%

Actuarial surplus split and EPS: the shareholders' surplus certified by the actuary was BDT 518.6m for 2024 and BDT 1,069.7m for 2025, so EPS doubled from BDT 4.19 to BDT 8.64 [4 p.141] [1 p.151]. The revenue account shows the same EPS [1 p.115]. The pages we read do not give the total valuation surplus, the policyholder bonus allocation or the actuarial basis, so we cannot say whether the jump came from a bigger total surplus or a bigger shareholders' slice. Both years' surplus was small relative to the fund: 1.34% and 2.63% of the closing life fund [24].

The dividend record: cash dividends rose from 20% of face value for 2016 to 25% (2017), 26% (2018) and 30% for each year 2019-2024, then 35% for 2025 [6 p.19] [1 p.29]. The 2025 dividend of BDT 3.50 a share costs BDT 433.1m, 40.5% of the shareholders' surplus; the 2024 dividend of BDT 3.00 took 71.6% [1 p.152] [24]. The 40th AGM, held virtually, announced the 35% cash dividend and shareholders approved the 2025 accounts, according to a company press release carried by The Daily Star on 3-Jul-2026 [20]. The Business Standard reported on 15-Aug-2024 that the 30% for 2023 was the fifth consecutive 30% dividend and that the AGM was set for 28-Sep-2024 [19]. Several of these dividends were approved years late: The Business Standard reported on 3-Aug-2023 that the accounts and AGMs for 2019-2021 were still pending [17], and The Daily Star reported on 19-Oct-2023 that the Appellate Division had given the company more time to hold its AGMs for 2020, 2021 and 2022 [18].

There is no stock dividend: share capital has been BDT 1,237.5m (123.75m shares) in every year 2021-2025 [1 p.18], and the board declared no bonus share as interim dividend for 2025 [1 p.35]. Delta does not report NAV per share, so P/B cannot be computed on a reported basis [1 p.151].

Ratios and peers: slowest fund growth and highest claims ratio of the three

The peer table uses each company's own 2025 Key Financial Indicators page, the IDRA-mandated format, so the labels match. Delta is the slowest grower of the three: gross premium +7.9% against +11.1% at NATLIFEINS and +14.7% at PRAGATILIF, and its life fund grew 5.0% against 17.0% and 18.4% [1 p.17] [8 p.251] [9 p.126] [24]. Its first-year premium grew fastest (+16.7%).

On the same definitions, Delta has the highest claims ratio (81.7% against 48.6% and 52.8%), the highest investment income relative to premium, and the only negative operating cash flow [24]. Its expense ratio, 28.1%, sits between the two; its headroom under the IDRA limit, 2.9%, is close to PRAGATILIF's 2.3% and well below NATLIFEINS's 12.0%. Delta's conservation ratio is 4.6pp below NATLIFEINS's and 1.5pp below PRAGATILIF's [1 p.17] [8 p.251] [9 p.126]. Lapse ratios are left out because Delta's formula differs (see persistency).

On market multiples, which are facts and not a view: Delta's market cap of BDT 8,526m is 0.21x its Dec-2025 life fund, against 0.14x for NATLIFEINS and 0.54x for PRAGATILIF; the reported 2025 dividend yields were 5.15%, 3.96% and 1.02% [23] [24] [1 p.18] [8 p.252] [9 p.126]. We do not compare P/E across the three because each company's EPS depends on its own actuarial surplus basis.

Governance: an administrator in 2021-2022, court reversal, settlement and a reconstituted board

The administrator and board history, from the record. IDRA suspended Delta's board in February 2021 and appointed a former IDRA member, Sultan-ul-Abedin Mollah, as administrator, as reported by The Business Standard and The Financial Express [12] [13]. On 1-Dec-2021 IDRA wrote to the Financial Institutions Division that an interim audit had found losses of Tk 3,687 crore (BDT 36.87bn) from embezzlement and other irregularities by the suspended board and management; both The Business Standard (via UNB) and The Daily Star reported the letter [10] [11]. The Daily Star reported that the former chief executive, Adeeba Rahman, called the report incomplete and said she had not been consulted [11]. These are allegations in a regulator's letter based on an interim report; we found no court finding on them.

The courts reversed and then settled the matter. On 6-Jan-2022 the High Court declared IDRA's suspension of the board and its appointment and extension of an administrator illegal, and restored the previous board [12] [13]. On 22-Aug-2022 the Appellate Division approved an amicable settlement between IDRA and a group of shareholders, reached under Finance Ministry supervision, under which both sides dropped their cases and a new board would hold the pending AGMs, according to The Business Standard [14]. IDRA withdrew the administrator on 19-Sep-2022 and the reconstituted board took charge on 20-Sep-2022, with a government observer on the board [15] [16]. The Business Standard listed the new directors as Suraiya Rahman, Zeyad Rahman, Adeeba Rahman and five new members including Hafiz Ahmed Majumdar [15]; Hafiz Ahmed Mazumder signs the 2025 accounts as chairman [1 p.102].

The aftermath was slow. The Business Standard reported on 3-Aug-2023 that a board meeting to review three years of accounts was halted again and that board seats were still being negotiated between sponsors, shareholders and independent directors [17]. The 2019 and 2020 financial statements were signed on 31-Oct-2023 [7 p.77] [6 p.79]. The Daily Star reported on 19-Oct-2023 that the Appellate Division appointed Fida M Kamal as independent director and audit committee chairman, after the previous audit committee had not met or adopted accounts for three years [18]; Barrister Fida M. Kamal signs the 2025 accounts as independent director [1 p.102].

Other governance points from the filings. The 2022 auditor's report noted that a family member held 22.7732% of shares at Dec-2022; the company's view is that the limits in S.R.O. 288 of 2016 do not apply because the shares were held before that rule and the Insurance Act 2010 [5 p.69]. The same report referred to income tax assessment disputes for 2005-06 to 2019-20 pending before the appellate authority and the High Court [5 p.69]. Separately, both The Business Standard and The Daily Star reported in December 2021 a VAT case over about Tk 35.2 crore (Tk 35.17-35.18 crore in the two reports) [10] [11]. For 2025, the auditor, Hoda Vasi Chowdhury & Co., gave an unqualified opinion with no emphasis of matter, the board met eight times, and two public shareholder directors co-opted to fill casual vacancies retire at the 40th AGM [1 p.34] [1 p.35]. The company also says Delta is above the IDRA thresholds 'with a few notable exceptions', which it does not list [1 p.34].

What's next: the FY2026 surplus in May 2027, claims vs premium, and the equity book

There is no forecast in this note. These are dated events that will show which way the lines move, each with its source.

Direction, from history only. If 9M 2026 trends hold, premium growth of about 12% and claims growth of about 15% [2 p.1] would keep claims near the 2025 ratio. Investment income rose BDT 713m between 2023 and 2025 as yields rose [1 p.17]; lower rates would reverse that over time as bonds roll. The equity book means the fair-value account and dividend income move with the DSE. LDC graduation, now set for 24-Nov-2029 after the UN General Assembly decision of 29-Oct-2026 [21] [22], matters to Delta only indirectly, through rates and household incomes; we found nothing in its filings that links it to the company.

Risks: claims vs premium, the equity book and thin expense headroom matter most

Each risk is tied to the line it moves and to the evidence in the filings.

Key questions: fund growth, the surplus and persistency decide shareholder returns

At BDT 68.9, DELTALIFE trades at 8.0x FY2025 EPS, a 5.1% cash yield on the FY2025 dividend and 0.20x its Sep-2026 life fund [23] [24]. At year-end prices the P/E was 19.0x for 2024 and 7.9x for 2025 [24]. The share price was BDT 196.50 at the end of 2021 and BDT 68.00 at the end of 2025 [1 p.18]. These are facts about the price, not a view on it.

FAQ

How does Delta Life earn its EPS?

EPS is the actuarial surplus made available to shareholders, BDT 1,069.7m in 2025, divided by 123.75m shares: BDT 8.64 [1 p.151].

Why is Delta Life's operating cash flow negative?

Claims and expenses exceed premium collected, and the company reports interest and dividends received under investing activities [6 p.79] [2 p.1].

How big is Delta Life's life fund?

BDT 40,729m at Dec-2025 and BDT 42,987m at Sep-2026; it was BDT 41,205m at Dec-2020 [1 p.18] [2 p.1] [6 p.19].

Is Delta Life within the IDRA expense limit?

Yes, narrowly: BDT 2,870m actual against BDT 2,954m allowable in 2025, 2.9% under [1 p.17].

What dividend did Delta Life pay for 2025?

35% in cash, BDT 3.50 a share or BDT 433.1m [1 p.152].

Why did Delta Life have an administrator?

IDRA suspended the board in February 2021 citing irregularities; the High Court declared this illegal in January 2022 and the administrator left in September 2022 after a court-approved settlement [12] [13] [15].

Sources

1. Delta Life Insurance Company Ltd. Annual Report 2025 (year to 31-Dec-2025) · link · accessed 2026-10-31
2. Delta Life Insurance Company Ltd. unaudited consolidated statements, nine months to 30-Sep-2026 · link · accessed 2026-10-31
3. Delta Life Insurance Company Ltd. unaudited consolidated statements, six months to 30-Jun-2026 · link · accessed 2026-10-31
4. Delta Life Insurance Company Ltd. Annual Report 2024 · link · accessed 2026-10-31
5. Delta Life Insurance Company Ltd. Annual Report 2022 (auditor's report) · link · accessed 2026-10-31
6. Delta Life Insurance Company Ltd. Annual Report 2020 (five-year highlights 2016-2020; statements signed 31-Oct-2023) · link · accessed 2026-10-31
7. Delta Life Insurance Company Ltd. Annual Report 2019 (statements signed 31-Oct-2023) · link · accessed 2026-10-31
8. National Life Insurance PLC Annual Report 2025 (Key Financial Indicators) · link · accessed 2026-10-31
9. Pragati Life Insurance PLC Annual Report 2025 (Key Financial Indicators) · link · accessed 2026-10-31
10. The Business Standard (UNB), 'IDRA finds Delta Life Insurance Board's involvement in embezzling Tk3,687cr' (4-Dec-2021) · link · accessed 2026-10-31
11. The Daily Star, 'Irregularities cost Delta Life Ins Tk 3,687cr' (4-Dec-2021) · link · accessed 2026-10-31
12. The Business Standard, 'HC declares insurance regulator's moves about Delta Life illegal' (6-Jan-2022) · link · accessed 2026-10-31
13. The Financial Express, 'Delta Life administrator declared illegal, board reinstated' (8-Jan-2022) · link · accessed 2026-10-31
14. The Business Standard, 'Supreme Court approves Delta Life-Idra settlement' (22-Aug-2022) · link · accessed 2026-10-31
15. The Business Standard, 'Delta Life administrator withdrawn, new board to take over on Tuesday' (19-Sep-2022) · link · accessed 2026-10-31
16. The Financial Express, 'IDRA withdraws administrator from Delta Life' (20-Sep-2022) · link · accessed 2026-10-31
17. The Business Standard, 'Why Delta Life again halted board meeting' (3-Aug-2023) · link · accessed 2026-10-31
18. The Daily Star, 'Delta Life's audit committee chair changed' (19-Oct-2023) · link · accessed 2026-10-31
19. The Business Standard, 'Delta Life declares 30% cash dividend for 5th year in a row' (15-Aug-2024) · link · accessed 2026-10-31
20. The Daily Star, 'Delta Life Insurance declares 35% cash dividend for 2025' (3-Jul-2026), based on the company's press release · link · accessed 2026-10-31
21. The Daily Star, 'Bangladesh gets 3 more years for LDC graduation' (30-Oct-2026) · link · accessed 2026-10-31
22. The Business Standard, 'Bangladesh gets 3 more years for LDC graduation' (30-Oct-2026) · link · accessed 2026-10-31
23. AnalystBro price data (TradingView feed): DSE:DELTALIFE, DSE:NATLIFEINS, DSE:PRAGATILIF daily bars to 29-Oct-2026 · link · accessed 2026-10-31
24. AnalystBro model for this report (workbook tabs below) · link · accessed 2026-10-31